AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DEXTRAN

10 registrations across 3 African markets— 6 active

Markets with DEXTRAN

Recent registrations

Brand / ProductMarketHolderStatusExpires
DEXTRIFERON SOLUTION🇬🇭GhanaactiveJun 2029
DEXTRIFERON SOLUTION🇬🇭GhanaactiveJun 2029
TEARS NATURALE PRESERVATIVE FREE🇿🇦South AfricaALCON LABORATORIES (SA) (PTY) LTDsuspendedAug 2025
IRON DEXTRAN USHER*🇿🇦South AfricaTHE PREMIER PHARMACEUTICAL CO LTDsuspendedDec 2022
DEXTRAN 40
Solution injectable pour perfusion / 100 gr / litre
🇹🇳TunisiaS.C.INFOMED FLUIDS S.R.L.expiredAug 2010
DEXTRAN 70
Solution injectable pour perfusion / 60 gr / Litre
🇹🇳TunisiaS.C.INFOMED FLUIDS S.R.L.expiredAug 2010
MACRODEX 6% IN NORMAL SALINE🇿🇦South AfricaAlliance Pharma (Pty) LtdactiveJan 1900
RESCUEFLOW🇿🇦South AfricaAlliance Pharma (Pty) LtdactiveJan 1900
PROMIT 150 mg/ml🇿🇦South AfricaAlliance Pharma (Pty) LtdactiveJan 1900
RHEOMACRODEX 10% IN NORMAL SALINE🇿🇦South AfricaAscendis Pharma (Pty) LtdactiveJan 1900

DEXTRAN in Africa — Regulatory Overview

DEXTRAN is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 6 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.